Her One raises €5.5 million

The start-up Her One focuses on nutritional supplements that are supposed to work from the intestines into the body. In doing so, it is aiming at a very specific target group.

Chanyu Xu, the founder of the start-up Her One, wants to score with nutritional supplements for women. Now the Berlin-based start-up has raised €5.5 million in a Series A funding round. Paris-based venture capitalist Five Seasons Ventures leads the round, joined by existing investors Rheingau Founders and IBB Ventures, which together had already invested €4.5 million in Her One. According to founder Chanyu Xu, the company's sales grew by 815 percent in 2020; the founder does not provide absolute figures.

Her One currently offers its products in the DACH region. With the money, the company wants to expand and enlarge its team. In addition, the start-up wants to develop other products on topics such as sleep and hormone balance, in addition to supplements for the gut.

Xu is encouraged that more and more venture capitalists and funds are focusing on business ideas that primarily target women, she told the portal Sifted. She herself founded Her One for this very reason. Because dietary supplements are developed by men for male bodies and needs, Xu wants to target the other half of the population, she says.

Her One's products rely on microbiomes to improve health, skin appearance, and metabolism from the gut. Founded in 2017 under the name One Labs, Her One is Xu's fourth startup creation.